1. Home
  2. TGL vs GOVX Comparison

TGL vs GOVX Comparison

Compare TGL & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Treasure Global Inc.

TGL

Treasure Global Inc.

SELL

Current Price

$3.57

Market Cap

2.7M

Sector

Technology

ML Signal

SELL

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

SELL

Current Price

$2.00

Market Cap

3.0M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
TGL
GOVX
Founded
2020
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7M
3.0M
IPO Year
2022
1996

Fundamental Metrics

Financial Performance
Metric
TGL
GOVX
Price
$3.57
$2.00
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $240.00
AVG Volume (30 Days)
★ 2.1M
279.9K
Earning Date
12-01-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 51.53
N/A
EPS
★ 16.03
N/A
Revenue
★ $5,169,784.00
$2,489,145.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 121.83
N/A
52 Week Low
$0.14
$0.11
52 Week High
$587.80
$1,095.50

Technical Indicators

Market Signals
Indicator
TGL
GOVX
Relative Strength Index (RSI) 81.19 57.20
Support Level $2.59 $0.11
Resistance Level $4.27 $4.60
Average True Range (ATR) 0.12 0.23
MACD 0.42 0.33
Stochastic Oscillator 75.82 66.43

Price Performance

Historical Comparison
TGL
GOVX

About TGL Treasure Global Inc.

Treasure Global Inc has created an online-to-offline e-commerce platform business model that offers consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retail or merchant settings. Its product is an internet application branded as the ZCITY app, a digital rewards and lifestyle platform based in Malaysia that uses artificial intelligence to offer personalized shopping deals, discounts, and rebates, and targets consumers by providing personalized deals based on their purchase history, location, and preferences. The company has two reportable segments: the ZCITY platform, which generates the maximum revenue, and Customized software development service.

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.

Share on Social Networks: